Pazopanib (Votrient) Side Effects, Cost for Sarcoma Treatment
Learn all about Pazopanib (Votrient) side effects and treatment for sarcoma. Pazopanib (Votrient) is a small molecule inhibitor of multiple tyrosine kinases that act as important molecular mediators of essential tumor angiogenic and oncogenic pathways.In April 2012, pazopanib (Votrient) was approved for the treatment of patients with advanced soft-tissue sarcoma who have received prior chemotherapy....